Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.

Akihiro HommaRikiya OnimaruKazuto MatsuuraHirotaka ShinomiyaTomohiro SakashitaKiyoto ShigaHiroyuki TachibanaKenichi NakamuraJunki MizusawaHideaki KitaharaJunko EbaHaruhiko FukudaMasato FujiiRyuichi Hayashi

Published in: Head & neck (2017)

These results indicated that this therapy is safe and well-tolerated at 7 cycles of cisplatin, which was determined to be the recommended number of cycles for locally advanced maxillary sinus SCC.

Keyphrases

papillary thyroid
cone beam computed tomography
early stage
clinical trial
palliative care
study protocol
low dose
phase iii
squamous cell
radiation therapy
phase ii
locally advanced
radiation induced
randomized controlled trial
stem cells
bone marrow
open label